Inicio › Enfermedad de Alzheimer › Texas
Ensayos clínicos de Enfermedad de Alzheimer en Texas
38 estudios sobre Enfermedad de Alzheimer buscan participantes en Texas.
Ciudades en Texas
- Dallas12 estudios
- Houston11 estudios
- Austin10 estudios
- San Antonio8 estudios
- Cypress7 estudios
- Beaumont6 estudios
- El Paso4 estudios
- Round Rock3 estudios
Texto oficial del estudio (inglés)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Austin
- Clinical Site, McKinney
- Clinical Site, Sugarland
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 12 nov 2026 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Epic Medical Research, LLC - Carrolton, Carrollton
- Horizon Clinical Research Center - Houston, Cypress
- Advanced Neurology Epilepsy and Sleep Center, El Paso
- y 2 más
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 12 nov 2026 · NCT06937229A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Advanced Neurology Epilepsy and Sleep Center, El Paso
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07011732A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Kerwin Medical Center- Site Number : 8400006, Dallas
ReclutandoFase 2
Edades de 55 a 85 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07688213Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
- Houston Methodist Research Institute, Houston
ReclutandoFase 1/2
Edades de 50 a 86 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07651319A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Gadolin Research, Beaumont
- Kerwin Medical Center, Dallas
- Houston Methodist Hospital, Houston
- y 3 más
ReclutandoFase 2
Edades de 55 a 85 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07589595A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Epic Medical Research, LLC - Carrolton, Carrollton
- Horizon Clinical Research Center - Houston, Cypress
- Epic Medical Research, LLC - Mesquite, Mesquite
- y 1 más
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07011745A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Horizon Clinical Research Group, Cypress
ReclutandoFase 2
Edades de 55 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06540833A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Senior Adults Specialty Research, Austin
- Gadolin Research, Beaumont
- The University of Texas Health Science Center at Houston, Houston
- y 1 más
ReclutandoFase 3
Edades de 55 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT07602582A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Gadolin Research, Beaumont
ReclutandoFase 3
Edades de 60 a 85 · Todos los sexos · Actualizado el 27 oct 2026 · NCT06976216A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Senior Adults Specialty Research, Austin
- Local Institution - 1260, Dallas
- Epic Medical Research LLC - DeSoto, DeSoto
- y 5 más
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 27 oct 2026 · NCT06585787[18F]PI-2620 Phase 3 Histopathological Study
- Baylor Research Institute, Dallas
- Sante Clinical Research, Kerrville
ReclutandoFase 3
Edades de 50 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT05641688A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Gadolin Research ( Site 1032), Beaumont
- Horizon Clinical Research Center - Houston ( Site 1026), Cypress
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 20 oct 2026 · NCT07033494Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Gadolin Research, LLC, Beaumont
- South Texas Research Institute - Brownsville, Brownsville
- Kerwin Medical Center, Dallas
- y 6 más
ReclutandoFase 3
Edades de 50 a 90 · Todos los sexos · Actualizado el 19 oct 2026 · NCT07177352A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Mt. Olympus Medical Research, Llc - Katy, Katy
ReclutandoFase 4
Edades de 50 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT07633470A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Local Institution - 0081, Dallas
- Central Texas Neurology Consultants, PA, Round Rock
ReclutandoFase 3
Edades de 60 a 85 · Todos los sexos · Actualizado el 8 oct 2026 · NCT06976203Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Kerwin Research Center, LLC - Oak Cliff, Dallas
- Kerwin Research Center, LLC in Texas, Dallas
ReclutandoFase 2
Edades de 55 a 80 · Todos los sexos · Actualizado el 7 oct 2026 · NCT06847321Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Pinnacle Clinical Research, Austin
- Horizon Clinical Research Center - Houston, Cypress
- ANESC Research, El Paso
- y 3 más
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 6 oct 2026 · NCT06808984NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
- Baylor College of Medicine, Houston
Reclutando
Edades de 55 a 90 · Todos los sexos · Actualizado el 1 oct 2026 · NCT07667478A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Kerwin Medical Center /ID# 277788, Dallas
ReclutandoFase 1/2
Edades de 50 a 90 · Todos los sexos · Actualizado el 18 sept 2026 · NCT07599670Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline
- Health Discovery Building, Austin
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 90 · Todos los sexos · Actualizado el 2 sept 2026 · NCT05907343Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- National Neuromuscular Research Institute, Austin
- University of Texas Southwestern, Dallas
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Kerwin Research and Memory Center, Dallas
ReclutandoFase 2/3Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Kerwin Research and Memory Center, Dallas
ReclutandoFase 2/3Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT05552157Epidemiology and Biomarker Study in Alzheimer's Disease
- Care Access - Houston, Houston
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 55 a 75 · Todos los sexos · Actualizado el 7 jul 2026 · NCT07142954Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
- University of Texas at Austin, Austin
ReclutandoFase 1 tempranaSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 jun 2026 · NCT06511752Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
- University of Texas at Austin, Austin
ReclutandoSe aceptan voluntarios sanos
Edades de 40 en adelante · Todos los sexos · Actualizado el 10 jun 2026 · NCT05741853Trial-Ready Cohort-Down Syndrome (TRC-DS)
- University of Texas Health San Antonio, Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, San Antonio
ReclutandoEstudio observacional
Edades de 25 a 55 · Todos los sexos · Actualizado el 18 may 2026 · NCT04165109Late Onset Alzheimer's Disease
- University of Texas Southwestern, Dallas
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 55 en adelante · Todos los sexos · Actualizado el 18 may 2026 · NCT05010603δ in Dementia Clinical Trials
- Univeristy of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio
Reclutando
Edades de 65 a 100 · Todos los sexos · Actualizado el 5 may 2026 · NCT05592678Stem Cell Therapy for Early Alzheimer's Disease
- The University of Texas Health Science Center at Houston (UTHealth), Houston
ReclutandoFase 1/2
Edades de 60 a 80 · Todos los sexos · Actualizado el 20 abr 2026 · NCT06775964Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Gadolin Research LLC, Beaumont
- Re:Cognition Health, Houston
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 60 a 90 · Todos los sexos · Actualizado el 15 abr 2026 · NCT06584357Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
- Houston Methodist Research Institute, Houston
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 90 · Todos los sexos · Actualizado el 6 abr 2026 · NCT05582200Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms
- University of Texas Health Science Center at San Antonio, San Antonio
Reclutando
Edades de 60 a 85 · Todos los sexos · Actualizado el 11 feb 2026 · NCT06801639Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Houston
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 2 feb 2026 · NCT07105709Paper-Based and Smartphone-Based Memory Supports
- UT Health Austin Comprehensive Memory Center, Austin
- Baylor Scott & White Healthcare, Temple
- Baylor University, Waco
Reclutando
Edades de 50 en adelante · Todos los sexos · Actualizado el 9 jul 2024 · NCT06444841Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- Caraday Healthcare, LLC, San Marcos
Reclutando
Edades de 50 en adelante · Todos los sexos · Actualizado el 12 mar 2024 · NCT05820919Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- The University of Texas at Austin, Austin
ReclutandoFase 4
Edades de 55 en adelante · Todos los sexos · Actualizado el 18 may 2022 · NCT03082755De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.